$UPB 4 SEC Filings

Filed On	Filing
17 Sep 2026	Form 4: Deykin Aaron, Chief Medical Officer Sold 895 shares ($4.91K)
17 Sep 2026	Form 4: Sutherland Everett Rand, Director Sold 2,095 shares ($11.5K)
17 Sep 2026	Form 4: Houghton Adam, Chief Business Officer Sold 700 shares ($3.84K)
17 Sep 2026	Form 4: Gray Michael, CFO and COO Sold 853 shares ($4.68K)
17 Sep 2026	Form 4: Ambrose Allison, General Counsel Sold 485 shares ($2.66K)
17 Jun 2026	Form 4: Gray Michael, CFO and COO Sold 853 shares ($5.2K)
17 Jun 2026	Form 4: Sutherland Everett Rand, Director Sold 2,095 shares ($12.8K)
17 Jun 2026	Form 4: Houghton Adam, Chief Business Officer Sold 700 shares ($4.27K)
17 Jun 2026	Form 4: Deykin Aaron, Chief Medical Officer Sold 895 shares ($5.46K)
17 Jun 2026	Form 4: Ambrose Allison, General Counsel Sold 477 shares ($2.91K)
11 Jun 2026	Form 4: Ruddy Marcella K., Director Granted 17,096 Stock Option (Right to Buy)
11 Jun 2026	Form 4: Renaud Ronald C Jr, Director Granted 17,096 Stock Option (Right to Buy)
11 Jun 2026	Form 4: Fleming Harold Edward, Director Granted 17,096 Stock Option (Right to Buy)
11 Jun 2026	Form 4: Beckman Daniella, Director Granted 17,096 Stock Option (Right to Buy)
11 Jun 2026	Form 4: Ratcliffe Liam, Director Granted 17,096 Stock Option (Right to Buy)
11 Jun 2026	Form 4: Chimovits Erez, Director Granted 17,096 Stock Option (Right to Buy)
17 Mar 2026	Form 4: Deykin Aaron, Chief Medical Officer Sold 894 shares ($8.31K)
17 Mar 2026	Form 4: Sutherland Everett Rand, Director Sold 2,093 shares ($19.4K)
17 Mar 2026	Form 4: Ambrose Allison, General Counsel Sold 475 shares ($4.41K)
17 Mar 2026	Form 4: Houghton Adam, Chief Business Officer Sold 699 shares ($6.49K)

Comments